Upsher-Smith Laboratories, LLC

Trusted

http://www.upsher-smith.com/

Last activity: 30.09.2026

Active

Categories: BusinessGrowthHealthTechIndustryInformationMedtechProductServiceSupply

Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company striving to improve the health and lives of patients. We formulate and manufacture generics and brands for a wide array of customers, backed by our attentive level of service, our strong industry relationships, and our dedication to uninterrupted supply.

LinkedIn Email

Likes

13.43K

Mentions

Overview

Location

United States, Minnesota, Maple Grove

Employees

501-1000

Phone

+1 763-315-2000

Founded date

1919

Mentions in press and media 15

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Aug 13, 2026	Bora Group Posts Record 2Q26 Revenue and Strong Profits as Margins expand and Operations Resume Demand-Driven Growth	HONG KONG SAR – Media OutReach Newswire – 13 August 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 2Q2026 and provides full year outlook update. 2Q26 Busin...
Nov 13, 2025	Bora 3Q25 Delivers Renewed Profitability as Efficiency and Scale Improves	Strategic realignment powering Bora’s dual-engine businesses model HONG KONG SAR – Media OutReach Newswire – 13 November 2025 – Bora Pharmaceuticals (TWSE: 6472) today announced its financial results and operational highlights for third qua...
Aug 16, 2021	Upsher-Smith Launches Carbamazepine Extended-Release Tablets, USP
Jun 25, 2021	Upsher-Smith Launches Isotretinoin Capsules
Jan 25, 2021	When You Can’t Stomach Your Migraine Medication, Make Sure Your Migraine Toolkit Has You Covered	(BPT) - How do you prepare for a migraine that threatens to derail your day? Many health care professionals recommend assembling a migraine toolkit, one stocked with essentials for easing migraine symptoms on the go, such as bottled water, ...
Jan 25, 2021	When You Can’t Stomach Your Migraine Medication, Make Sure Your Migraine Toolkit Has You Covered	(BPT) - How do you prepare for a migraine that threatens to derail your day? Many health care professionals recommend assembling a migraine toolkit, one stocked with essentials for easing migraine symptoms on the go, such as bottled water, ...
Dec 15, 2020	Upsher-Smith Launches Ramelteon Tablets
Apr 20, 2017	Term Sheet — Thursday, April 20	UNCOMFORTABLE REALITY The following is from the latest print edition of Fortune, where I write a regular column about technology and startups called “Boom with a View.” Paid Content What you need to know about growing cyberattacks From Extr...
Mar 16, 2012	Equity analyst hired as Unigene CFO to reduce debt	“I’d liken this [move] to taking the other side of the consensus view on Wall Street. How can I find something out that Wall Street doesn’t know?” He said his move from the analyst chair to the CFO desk was not so uncommon these days, espec...
Feb 8, 2012	Success or withdrawal hang in balance for Shire blood pressure drug	Although the Irish pharmaceutical company, which has U.S. headquarters in the Philadelphia area, no longer manufactures the drug, it agreed to do the additional tests because it holds the new drug application for ProAmatine and did not want...
Dec 5, 2011	Shire agrees to more clinical trials for blood pressure drug, but threat of FDA action lingers	Shire had resisted repeated requests for additional testing, arguing it had satisfied the testing requirements in 2005, but the FDA said it has not verified the clinical benefits of the drug. A letter sent to Shire in May 2001 said the comp...
	Success or withdrawal hang in balance for Shire blood pressure drug	Shire (NASDAQ:SHPGY) has reached an agreement with U.S. regulators in the long-running saga over its low blood pressure drug, ProAmatine, that rests on the drug generating positive results in two clinical trials, or else face a withdrawal o...
	Equity analyst hired as Unigene CFO to reduce debt	Unigene Laboratories has hired a chief financial officer as it continues its quest to develop its product pipeline and bring firmer financial footing to the biotechnology company, particularly in reducing its $43 million debt. David Moskowi...
	Shire agrees to more clinical trials for blood pressure drug, but threat of FDA action lingers	One year after Shire (NASDAQ:SHPGY) pulled its drug for low blood pressure, ProAmatine, from the market after reaching an impasse with the U.S. Food and Drug Administration, it has agreed to do the additional clinical tests the regulator wa...

Reviews 0

FAQ about Upsher-Smith Laboratories, LLC

When was Upsher-Smith Laboratories, LLC founded?

Upsher-Smith Laboratories, LLC was founded in 1919.

What has the press written about Upsher-Smith Laboratories, LLC?

Parsers VC has collected 15 articles mentioning Upsher-Smith Laboratories, LLC, among them “Bora Group Posts Record 2Q26 Revenue and Strong Profits as Margins expand and Operations Resume Demand-Driven Growth” (Aug 13, 2026) and “Bora 3Q25 Delivers Renewed Profitability as Efficiency and Scale Improves” (Nov 13, 2025).

Is Upsher-Smith Laboratories, LLC still active?

Yes, Upsher-Smith Laboratories, LLC is active; its latest activity on Parsers VC dates from Sep 30, 2026.